Assessment System of Sarcopenia in Lung Cancer Patients

Launched by WEST CHINA HOSPITAL · Mar 18, 2024

Keywords

ClinConnect Summary

This clinical trial, titled "Assessment System of Sarcopenia in Lung Cancer Patients," is looking to improve how we diagnose and understand a condition called sarcopenia, which involves the loss of muscle mass and strength, in patients with lung cancer. The study will use a combination of ultrasound and imaging techniques like CT or MRI scans to see how well these methods can help in identifying sarcopenia, predicting how well patients will do after surgery, and assessing how nutritional support can aid recovery during and after treatment.

To participate in this trial, individuals must be hospitalized and scheduled for surgery to remove lung cancer, and they should have had a CT or MRI scan within the past week. However, certain patients may not be eligible, such as those with severe swelling in their limbs or those with conditions that could interfere with their ability to participate. Participants can expect to undergo imaging assessments and may help provide valuable information that could improve care for future lung cancer patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Hospitalized patients scheduled for radical resection of lung cancer.
• • 2. With a CT/MRI examination within 1 week.
• • 3. The compliance of examination was good.
• Exclusion Criteria:
• • 1. Amputated arm or leg.
• • 2. Severe oedema (oedema higher than knee level).
• • 3. Implantable pacemaker.
• • 4. Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study.